Navigation Links
Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
Date:8/5/2008

NEW HAVEN, Conn., Aug. 5 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Company"), a development-stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic-resistant infections, announced today that company representatives are giving three presentations at two conferences this week.

Gordon Research Conference on Medicinal Chemistry, August 3-8

Ashoke Bhattacharjee, Ph.D, Senior Scientist, presented at the Gordon Research Conference on Medicinal Chemistry this week at Colby Sawyer College, New London, NH. Dr. Bhattacharjee introduced Rib-X's enhanced macrolide program in a poster session titled, "Structure-Based Drug Design Targeting Infectious Disease: Overcoming Resistance and Extending the Antimicrobial Spectrum of Macrolide Antibiotics." In his presentation on August 3 and 4, Dr. Bhattacharjee highlighted how the combination of structural insights from X-ray crystallographic studies of known and new antibiotics bound to the bacterial 50S ribosomal subunit with data-driven computational chemistry tools allows for a fresh look at macrolide antibiotics.

Additionally, Graham Johnson, Ph.D, Chief Research Officer of Rib-X will give a presentation in the "Late-Breaking Topics" session, Thursday, August 7. The title of the talk is "Discovery and Clinical Development of radezolid (RX-1741), a Designer Oxazolidinone" and will highlight the company's proprietary discovery process utilizing structural, computational and chemistry approaches; radezolid has distinct physical properties as well as a promising efficacy and safety profile.

Drug Discovery & Development of Innovative Therapeutics World Conference, August 4-7

Joseph DeVito, Ph.D, Associate Director, Discovery Biology, Rib-X Pharmaceuticals, Inc., is presenting Rib-X's RX-04 program at IBC's 12th Annual Drug Discovery & Development of Innovative Therapeutics World Conference Technology Conference today at 11:00 A
'/>"/>

SOURCE Rib-X Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections
2. Rib-X Pharmaceuticals Renews Collaborative Agreement with the Medical Research Council
3. Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference
4. Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis
5. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
6. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
7. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
8. Jazz Pharmaceuticals, Inc. Completes Enrollment in First of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia
9. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
10. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
11. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...TSBURGH,Nov.24/PRNewswire/-- ,, WHAT:RomHoubens...winganautoaccident,wasactuallyfullyconsciousandawa...icasegment.TheDynaVoxEyeMaxwasfeaturedinthesegment...conditionscanunlockcommunication. ,, WHEN:GoodM...at www.dynavoxtech.com ,, WHO:RomHoubens...
(Date:11/24/2009)...DCLIFFLAKE,N.J.andNEWYORK,Nov.24/PRNewswire/-- Ei...dDrugAdministration(FDA)hasacceptedforreviewEisai,...74;(donepezilHClextendedrelease)tabletsforthetreat...ewhigherdoseformulationcontains23mgofdonepezilHCli...ystemthatallowsforgradualreleaseofthedrug.TheNDAis...
(Date:11/24/2009)...EIGH,N.C.,Nov.24/PRNewswire/--PharmaceuticalInstit...forthepharmaceuticalandbiotechindustry,todayannoun...ace .Thenew HospitalMarketplace e-courseisthenewes...M) series,acomprehensiveseriesofe-coursesdesignedt...etsknowledgeforcommercialprofessionals. ,, Then...
Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace 2Brain Training Keeps Older Drivers Safe Behind the Wheel 57315 1Brain Training Keeps Older Drivers Safe Behind the Wheel 57315 2Brain Training Keeps Older Drivers Safe Behind the Wheel 57315 3BioSpecifics Technologies Corp Stock Trading Halted Today 14076 1GENova and TheraGlass in advanced negotiations 57312 1GENova and TheraGlass in advanced negotiations 57312 2GENova and TheraGlass in advanced negotiations 57312 3
...--May 2, 2007 - Acorda Therapeutics, Inc.(R),(Nasd...ical trial,of Fampridine-SR in people with multipl...ogy meeting. Andrew Goodman, M.D.,Director of the...chester, presented top-line results on walking abi...ubject global impressions.,Dr. Goodman also presen...
...May 02, 2007 /PRNewswire-FirstCall/ --,Genelabs Te...on was,made today at the 20th International Confer...ngs, California, on a,non-nucleoside hepatitis C v...labs. , The oral presentation was given by Christo...istry at Genelabs, entitled,"GL59728: A Potent All...
Other Medicine Technology:Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 2Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 3Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 4Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 5Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 6Acorda Therapeutics Presents Data from its Phase 3 Study of,Fampridine-SR in Multiple Sclerosis at the American Academy of,Neurology Meeting 7Genelabs Technologies Announces Presentation of Data on,Non-Nucleoside HCV Polymerase Inhibitor at 20th International,Conference on Antiviral Research Meeting 2Genelabs Technologies Announces Presentation of Data on,Non-Nucleoside HCV Polymerase Inhibitor at 20th International,Conference on Antiviral Research Meeting 3
(Date:11/24/2009)...USNewswire/--Parties,familydinners,andothergatheri...tthemerrimentcanchangetomiseryiffoodmakesyouorothe.../prnh/20090824/FDALOGO ) ,, Typicalsymptomsoffo...toms,whichcanstartanywherefromhourstodaysaftercont...sisthatpracticingfourbasicfoodsafetymeasurescanhel...
(Date:11/24/2009)...USNewswire/--IPROhasachieveditsthirdconsecutiveISO...dardfocusedonfulfillingcustomerrequirements,enhanc...nessperformance.CertificationtoISO9001:2008bySGSIn...ManagementSystem(QMS)haspassedarigorousexternalaud...ndAlbany,NewYorkaswellasatitsaffiliateLogiqual,LLC...
(Date:11/24/2009)...--Mostpeoplelookforwardtokickingofftheholidayseaso...andfamily.TheMacombCountyHealthDepartmentremindsyo...elingandbeinginlargegroupsareeasywaystospreadfluge... VACCINATION ,, Thefirstandmostimportantstepis...ainsttheH1N1strainoftheflu.TheMacombCountyHealthDe...
(Date:11/24/2009)...ire/--Nextmonth,UnitedHealthcarewilloffertwofreeMe...icanseniorsunderstandthebasicsofMedicare.Following...74;Goldclass,aLatin-infusedfitnessprogramthatblend... ,, UnitedHealthcarewilloffertheseseminarsinSpa...rningabouttheirhealthcareoptions. Thereareapproxi...
(Date:11/24/2009)...l/--CenteneCorporation(NYSE: CNC )todayannouncedth...neasoneoftwoCoordinatedCareOrganizationstoparticip...sippiCAN),acoordinatedcareprogramforMississippiMed...toexecuteacontractinwhichthecompanywillserveeligib...agnolia). ,, BasedinJackson,Miss.,Magnoliawillw...
Breaking Medicine News(10 mins):Health News:FDA Consumer Health Information: Food Safety Tips for Healthy Holidays 2Health News:IPRO Earns Third Consecutive Quality Management Certification 2Health News:Tips To Enjoy a Flu-Free Holiday Season 2Health News:UnitedHealthcare To Offer Seniors Hispanic-Centered Medicare Education Seminars Combined With a Latin-Themed Fitness Program 2Health News:Centene Corporation Receives Notification of Intent to Contract From the State of Mississippi 2
... Chicago, Ill.--The interaction of sex, age and e...val in metastatic colorectal cancer (MCRC) patient... Southern California (USC) and USC/Norris Comprehe...t gender also plays an important role in overall s...
... The passing of time makes ovaries lose their abi...rmones which regulate the menstrual cycle. In this...sical and psychical changes such as hot flushes, s...ain, the average age for the cessation of the mens...
...ETROIT, May 29 Caraco Pharmaceutical,Laboratories...he fourth,quarter and the year ended March 31, 200...ion, respectively, as compared to $32.7 million an...08,respectively, as compared to net income of $9.5...
...merifit Brands Educates Consumers about Urinary He... realize its,prevalence, urinary tract infections ...n in the body, and account for more than 8 million...lifetime.(2),However, many women do not realize th...
...esearch adds to what is known about relationship b... The risk of developing,type 2 diabetes in women ...ow cardiorespiratory fitness or higher Body Mass I... American,College of Sports Medicine (ACSM). An in...
...air of studies features biomechanical analysis of ...flip-flops as their primary footwear option during...and a change in their stride, according to,researc...s study began with the observation,that most peopl...
Other Medicine News:Health News:USC study finds sex, age and ethnicity assciated with colorectal cancer survival 2Health News:Post-menopausal therapy to improve women's quality of life 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008 3Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008 4Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008 5Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008 6Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008 7Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008 8Health News:AZO Answers the Burning Question: What's Up Down There? 2Health News:AZO Answers the Burning Question: What's Up Down There? 3Health News:AZO Answers the Burning Question: What's Up Down There? 4Health News:Studies Define Type 2 Diabetes Risk Factors in Women, Adolescents 2Health News:Studies Define Type 2 Diabetes Risk Factors in Women, Adolescents 3Health News:Studies Define Type 2 Diabetes Risk Factors in Women, Adolescents 4Health News:Flip-Flops, Heels Examined for Performance, Impact 2Health News:Flip-Flops, Heels Examined for Performance, Impact 3
Near Point Card/Newspaper 8 to 48 - BC2203
Near Point Diagnostic Card Set - BC11982
Near Point Card 4 1/2 to 24 PT - BC2202
... references to many common print sizes, from newsp...size. This provides the examiner a starting point ... black ink on yellow styrene for increased contras.... Other notations include Jaeger, M notation, lowe...
Medicine Products: